nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—Hyperthyroidism—Dextrothyroxine—hypothyroidism	0.0262	0.0287	CcSEcCtD
Sibutramine—Hyperthyroidism—Levothyroxine—hypothyroidism	0.0262	0.0287	CcSEcCtD
Sibutramine—Muscle twitching—Liothyronine—hypothyroidism	0.0215	0.0235	CcSEcCtD
Sibutramine—Hyperthyroidism—Liotrix—hypothyroidism	0.0193	0.0211	CcSEcCtD
Sibutramine—Phlebitis—Liothyronine—hypothyroidism	0.0178	0.0194	CcSEcCtD
Sibutramine—Cardiac failure congestive—Liothyronine—hypothyroidism	0.0169	0.0185	CcSEcCtD
Sibutramine—Angina pectoris—Liothyronine—hypothyroidism	0.0129	0.0141	CcSEcCtD
Sibutramine—Acute coronary syndrome—Liothyronine—hypothyroidism	0.0116	0.0127	CcSEcCtD
Sibutramine—Myocardial infarction—Liothyronine—hypothyroidism	0.0116	0.0127	CcSEcCtD
Sibutramine—Intestinal obstruction—Liotrix—hypothyroidism	0.0112	0.0122	CcSEcCtD
Sibutramine—Abscess—Liotrix—hypothyroidism	0.00964	0.0105	CcSEcCtD
Sibutramine—Arrhythmia—Liothyronine—hypothyroidism	0.00947	0.0104	CcSEcCtD
Sibutramine—SLC6A4—Monoamine Transport—SLC5A7—hypothyroidism	0.00915	0.108	CbGpPWpGaD
Sibutramine—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.00905	0.00988	CcSEcCtD
Sibutramine—Hyperkinesia—Levothyroxine—hypothyroidism	0.00905	0.00988	CcSEcCtD
Sibutramine—Cellulitis—Liotrix—hypothyroidism	0.00839	0.00917	CcSEcCtD
Sibutramine—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.0083	0.00907	CcSEcCtD
Sibutramine—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.0083	0.00907	CcSEcCtD
Sibutramine—SLC6A2—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.00828	0.0976	CbGpPWpGaD
Sibutramine—Creatinine increased—Liotrix—hypothyroidism	0.00801	0.00876	CcSEcCtD
Sibutramine—Increased appetite—Dextrothyroxine—hypothyroidism	0.00801	0.00876	CcSEcCtD
Sibutramine—Increased appetite—Levothyroxine—hypothyroidism	0.00801	0.00876	CcSEcCtD
Sibutramine—Hypertension—Liothyronine—hypothyroidism	0.00797	0.00871	CcSEcCtD
Sibutramine—SLC6A2—Monoamine Transport—SLC5A7—hypothyroidism	0.00786	0.0927	CbGpPWpGaD
Sibutramine—Muscle twitching—Liotrix—hypothyroidism	0.00777	0.00849	CcSEcCtD
Sibutramine—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00771	0.00843	CcSEcCtD
Sibutramine—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00771	0.00843	CcSEcCtD
Sibutramine—Affect lability—Dextrothyroxine—hypothyroidism	0.00741	0.0081	CcSEcCtD
Sibutramine—Affect lability—Levothyroxine—hypothyroidism	0.00741	0.0081	CcSEcCtD
Sibutramine—Tachycardia—Liothyronine—hypothyroidism	0.00735	0.00804	CcSEcCtD
Sibutramine—SLC6A3—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.00734	0.0864	CbGpPWpGaD
Sibutramine—Fluid retention—Liotrix—hypothyroidism	0.00724	0.00791	CcSEcCtD
Sibutramine—Blood urea increased—Liotrix—hypothyroidism	0.0072	0.00787	CcSEcCtD
Sibutramine—Cardiac arrest—Levothyroxine—hypothyroidism	0.00716	0.00782	CcSEcCtD
Sibutramine—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00716	0.00782	CcSEcCtD
Sibutramine—Mood swings—Dextrothyroxine—hypothyroidism	0.00713	0.00779	CcSEcCtD
Sibutramine—Mood swings—Levothyroxine—hypothyroidism	0.00713	0.00779	CcSEcCtD
Sibutramine—Hypotension—Liothyronine—hypothyroidism	0.00704	0.00769	CcSEcCtD
Sibutramine—Dehydration—Dextrothyroxine—hypothyroidism	0.007	0.00765	CcSEcCtD
Sibutramine—Dehydration—Levothyroxine—hypothyroidism	0.007	0.00765	CcSEcCtD
Sibutramine—SLC6A3—Monoamine Transport—SLC5A7—hypothyroidism	0.00697	0.0821	CbGpPWpGaD
Sibutramine—Hyperkinesia—Liotrix—hypothyroidism	0.00665	0.00727	CcSEcCtD
Sibutramine—Muscular weakness—Levothyroxine—hypothyroidism	0.00664	0.00726	CcSEcCtD
Sibutramine—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00664	0.00726	CcSEcCtD
Sibutramine—Sepsis—Liotrix—hypothyroidism	0.00662	0.00723	CcSEcCtD
Sibutramine—Dysphagia—Levothyroxine—hypothyroidism	0.00651	0.00711	CcSEcCtD
Sibutramine—Dysphagia—Dextrothyroxine—hypothyroidism	0.00651	0.00711	CcSEcCtD
Sibutramine—Phlebitis—Liotrix—hypothyroidism	0.00643	0.00702	CcSEcCtD
Sibutramine—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00634	0.00693	CcSEcCtD
Sibutramine—Angina pectoris—Levothyroxine—hypothyroidism	0.00634	0.00693	CcSEcCtD
Sibutramine—Cardiac failure congestive—Liotrix—hypothyroidism	0.00611	0.00667	CcSEcCtD
Sibutramine—Body temperature increased—Liothyronine—hypothyroidism	0.00596	0.00651	CcSEcCtD
Sibutramine—Increased appetite—Liotrix—hypothyroidism	0.00589	0.00644	CcSEcCtD
Sibutramine—Renal impairment—Liotrix—hypothyroidism	0.00582	0.00636	CcSEcCtD
Sibutramine—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00572	0.00625	CcSEcCtD
Sibutramine—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00572	0.00625	CcSEcCtD
Sibutramine—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00569	0.00621	CcSEcCtD
Sibutramine—Myocardial infarction—Levothyroxine—hypothyroidism	0.00569	0.00621	CcSEcCtD
Sibutramine—Hypoglycaemia—Liotrix—hypothyroidism	0.00567	0.0062	CcSEcCtD
Sibutramine—Cerebrovascular accident—Liotrix—hypothyroidism	0.00565	0.00618	CcSEcCtD
Sibutramine—Sweating—Dextrothyroxine—hypothyroidism	0.00556	0.00608	CcSEcCtD
Sibutramine—Sweating—Levothyroxine—hypothyroidism	0.00556	0.00608	CcSEcCtD
Sibutramine—Affect lability—Liotrix—hypothyroidism	0.00545	0.00596	CcSEcCtD
Sibutramine—Cardiac arrest—Liotrix—hypothyroidism	0.00527	0.00575	CcSEcCtD
Sibutramine—Mood swings—Liotrix—hypothyroidism	0.00525	0.00573	CcSEcCtD
Sibutramine—Blood creatinine increased—Liotrix—hypothyroidism	0.00519	0.00567	CcSEcCtD
Sibutramine—Dehydration—Liotrix—hypothyroidism	0.00515	0.00563	CcSEcCtD
Sibutramine—Hypokalaemia—Liotrix—hypothyroidism	0.00504	0.00551	CcSEcCtD
Sibutramine—Muscular weakness—Liotrix—hypothyroidism	0.00488	0.00534	CcSEcCtD
Sibutramine—Abdominal distension—Liotrix—hypothyroidism	0.00482	0.00527	CcSEcCtD
Sibutramine—Dysphagia—Liotrix—hypothyroidism	0.00479	0.00523	CcSEcCtD
Sibutramine—Angina pectoris—Liotrix—hypothyroidism	0.00466	0.0051	CcSEcCtD
Sibutramine—Arrhythmia—Levothyroxine—hypothyroidism	0.00465	0.00508	CcSEcCtD
Sibutramine—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00465	0.00508	CcSEcCtD
Sibutramine—Bronchitis—Liotrix—hypothyroidism	0.0046	0.00503	CcSEcCtD
Sibutramine—Alopecia—Dextrothyroxine—hypothyroidism	0.0046	0.00503	CcSEcCtD
Sibutramine—Alopecia—Levothyroxine—hypothyroidism	0.0046	0.00503	CcSEcCtD
Sibutramine—Tension—Levothyroxine—hypothyroidism	0.00445	0.00486	CcSEcCtD
Sibutramine—Tension—Dextrothyroxine—hypothyroidism	0.00445	0.00486	CcSEcCtD
Sibutramine—Nervousness—Dextrothyroxine—hypothyroidism	0.0044	0.00481	CcSEcCtD
Sibutramine—Nervousness—Levothyroxine—hypothyroidism	0.0044	0.00481	CcSEcCtD
Sibutramine—SLC6A4—Synaptic Vesicle Pathway—CLTC—hypothyroidism	0.00437	0.0514	CbGpPWpGaD
Sibutramine—Tremor—Levothyroxine—hypothyroidism	0.00425	0.00464	CcSEcCtD
Sibutramine—Tremor—Dextrothyroxine—hypothyroidism	0.00425	0.00464	CcSEcCtD
Sibutramine—Acute coronary syndrome—Liotrix—hypothyroidism	0.00421	0.0046	CcSEcCtD
Sibutramine—Renal failure—Liotrix—hypothyroidism	0.0042	0.00458	CcSEcCtD
Sibutramine—Myocardial infarction—Liotrix—hypothyroidism	0.00418	0.00457	CcSEcCtD
Sibutramine—Agitation—Dextrothyroxine—hypothyroidism	0.00417	0.00455	CcSEcCtD
Sibutramine—Agitation—Levothyroxine—hypothyroidism	0.00417	0.00455	CcSEcCtD
Sibutramine—Angioedema—Dextrothyroxine—hypothyroidism	0.00414	0.00453	CcSEcCtD
Sibutramine—Angioedema—Levothyroxine—hypothyroidism	0.00414	0.00453	CcSEcCtD
Sibutramine—Sweating—Liotrix—hypothyroidism	0.00409	0.00447	CcSEcCtD
Sibutramine—Palpitations—Dextrothyroxine—hypothyroidism	0.00401	0.00438	CcSEcCtD
Sibutramine—Palpitations—Levothyroxine—hypothyroidism	0.00401	0.00438	CcSEcCtD
Sibutramine—Convulsion—Dextrothyroxine—hypothyroidism	0.00393	0.00429	CcSEcCtD
Sibutramine—Convulsion—Levothyroxine—hypothyroidism	0.00393	0.00429	CcSEcCtD
Sibutramine—Arthralgia—Levothyroxine—hypothyroidism	0.00386	0.00422	CcSEcCtD
Sibutramine—Arthralgia—Dextrothyroxine—hypothyroidism	0.00386	0.00422	CcSEcCtD
Sibutramine—Anxiety—Levothyroxine—hypothyroidism	0.00385	0.0042	CcSEcCtD
Sibutramine—Anxiety—Dextrothyroxine—hypothyroidism	0.00385	0.0042	CcSEcCtD
Sibutramine—Hypoaesthesia—Liotrix—hypothyroidism	0.00381	0.00417	CcSEcCtD
Sibutramine—Confusional state—Dextrothyroxine—hypothyroidism	0.00373	0.00408	CcSEcCtD
Sibutramine—Confusional state—Levothyroxine—hypothyroidism	0.00373	0.00408	CcSEcCtD
Sibutramine—Shock—Dextrothyroxine—hypothyroidism	0.00364	0.00398	CcSEcCtD
Sibutramine—Shock—Levothyroxine—hypothyroidism	0.00364	0.00398	CcSEcCtD
Sibutramine—Tachycardia—Dextrothyroxine—hypothyroidism	0.00361	0.00395	CcSEcCtD
Sibutramine—Tachycardia—Levothyroxine—hypothyroidism	0.00361	0.00395	CcSEcCtD
Sibutramine—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00358	0.00391	CcSEcCtD
Sibutramine—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00358	0.00391	CcSEcCtD
Sibutramine—Arrhythmia—Liotrix—hypothyroidism	0.00342	0.00374	CcSEcCtD
Sibutramine—Alopecia—Liotrix—hypothyroidism	0.00339	0.0037	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00337	0.00368	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00337	0.00368	CcSEcCtD
Sibutramine—Insomnia—Dextrothyroxine—hypothyroidism	0.00335	0.00366	CcSEcCtD
Sibutramine—Insomnia—Levothyroxine—hypothyroidism	0.00335	0.00366	CcSEcCtD
Sibutramine—Dyspnoea—Levothyroxine—hypothyroidism	0.0033	0.00361	CcSEcCtD
Sibutramine—Dyspnoea—Dextrothyroxine—hypothyroidism	0.0033	0.00361	CcSEcCtD
Sibutramine—Flatulence—Liotrix—hypothyroidism	0.00329	0.00359	CcSEcCtD
Sibutramine—Tension—Liotrix—hypothyroidism	0.00327	0.00358	CcSEcCtD
Sibutramine—Dysgeusia—Liotrix—hypothyroidism	0.00327	0.00357	CcSEcCtD
Sibutramine—Nervousness—Liotrix—hypothyroidism	0.00324	0.00354	CcSEcCtD
Sibutramine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00324	0.0382	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00316	0.0372	CbGpPWpGaD
Sibutramine—Vision blurred—Liotrix—hypothyroidism	0.00314	0.00343	CcSEcCtD
Sibutramine—Tremor—Liotrix—hypothyroidism	0.00312	0.00341	CcSEcCtD
Sibutramine—Agitation—Liotrix—hypothyroidism	0.00306	0.00335	CcSEcCtD
Sibutramine—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00305	0.00333	CcSEcCtD
Sibutramine—Feeling abnormal—Levothyroxine—hypothyroidism	0.00305	0.00333	CcSEcCtD
Sibutramine—Angioedema—Liotrix—hypothyroidism	0.00305	0.00333	CcSEcCtD
Sibutramine—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00303	0.00331	CcSEcCtD
Sibutramine—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00303	0.00331	CcSEcCtD
Sibutramine—Syncope—Liotrix—hypothyroidism	0.00299	0.00327	CcSEcCtD
Sibutramine—Palpitations—Liotrix—hypothyroidism	0.00295	0.00322	CcSEcCtD
Sibutramine—Urticaria—Dextrothyroxine—hypothyroidism	0.00294	0.00321	CcSEcCtD
Sibutramine—Urticaria—Levothyroxine—hypothyroidism	0.00294	0.00321	CcSEcCtD
Sibutramine—Loss of consciousness—Liotrix—hypothyroidism	0.00293	0.0032	CcSEcCtD
Sibutramine—Body temperature increased—Levothyroxine—hypothyroidism	0.00293	0.0032	CcSEcCtD
Sibutramine—Abdominal pain—Levothyroxine—hypothyroidism	0.00293	0.0032	CcSEcCtD
Sibutramine—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00293	0.0032	CcSEcCtD
Sibutramine—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00293	0.0032	CcSEcCtD
Sibutramine—Convulsion—Liotrix—hypothyroidism	0.00289	0.00316	CcSEcCtD
Sibutramine—Hypertension—Liotrix—hypothyroidism	0.00288	0.00315	CcSEcCtD
Sibutramine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00287	0.0338	CbGpPWpGaD
Sibutramine—Arthralgia—Liotrix—hypothyroidism	0.00284	0.0031	CcSEcCtD
Sibutramine—Chest pain—Liotrix—hypothyroidism	0.00284	0.0031	CcSEcCtD
Sibutramine—Anxiety—Liotrix—hypothyroidism	0.00283	0.00309	CcSEcCtD
Sibutramine—Confusional state—Liotrix—hypothyroidism	0.00274	0.003	CcSEcCtD
Sibutramine—Anaphylactic shock—Liotrix—hypothyroidism	0.00272	0.00297	CcSEcCtD
Sibutramine—Oedema—Liotrix—hypothyroidism	0.00272	0.00297	CcSEcCtD
Sibutramine—SLC6A4—NRF2 pathway—SLC5A7—hypothyroidism	0.00272	0.032	CbGpPWpGaD
Sibutramine—Infection—Liotrix—hypothyroidism	0.0027	0.00295	CcSEcCtD
Sibutramine—Shock—Liotrix—hypothyroidism	0.00268	0.00293	CcSEcCtD
Sibutramine—Tachycardia—Liotrix—hypothyroidism	0.00266	0.0029	CcSEcCtD
Sibutramine—Asthenia—Dextrothyroxine—hypothyroidism	0.00265	0.0029	CcSEcCtD
Sibutramine—Asthenia—Levothyroxine—hypothyroidism	0.00265	0.0029	CcSEcCtD
Sibutramine—Hyperhidrosis—Liotrix—hypothyroidism	0.00263	0.00288	CcSEcCtD
Sibutramine—Pruritus—Dextrothyroxine—hypothyroidism	0.00262	0.00286	CcSEcCtD
Sibutramine—Pruritus—Levothyroxine—hypothyroidism	0.00262	0.00286	CcSEcCtD
Sibutramine—Anorexia—Liotrix—hypothyroidism	0.00259	0.00284	CcSEcCtD
Sibutramine—Hypotension—Liotrix—hypothyroidism	0.00254	0.00278	CcSEcCtD
Sibutramine—Diarrhoea—Levothyroxine—hypothyroidism	0.00253	0.00277	CcSEcCtD
Sibutramine—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00253	0.00277	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00248	0.00271	CcSEcCtD
Sibutramine—Insomnia—Liotrix—hypothyroidism	0.00246	0.00269	CcSEcCtD
Sibutramine—Paraesthesia—Liotrix—hypothyroidism	0.00244	0.00267	CcSEcCtD
Sibutramine—Dyspnoea—Liotrix—hypothyroidism	0.00243	0.00265	CcSEcCtD
Sibutramine—Decreased appetite—Liotrix—hypothyroidism	0.00237	0.00259	CcSEcCtD
Sibutramine—Vomiting—Levothyroxine—hypothyroidism	0.00235	0.00257	CcSEcCtD
Sibutramine—Vomiting—Dextrothyroxine—hypothyroidism	0.00235	0.00257	CcSEcCtD
Sibutramine—SLC6A2—NRF2 pathway—SLC5A7—hypothyroidism	0.00234	0.0275	CbGpPWpGaD
Sibutramine—Rash—Dextrothyroxine—hypothyroidism	0.00233	0.00255	CcSEcCtD
Sibutramine—Rash—Levothyroxine—hypothyroidism	0.00233	0.00255	CcSEcCtD
Sibutramine—Dermatitis—Levothyroxine—hypothyroidism	0.00233	0.00255	CcSEcCtD
Sibutramine—Dermatitis—Dextrothyroxine—hypothyroidism	0.00233	0.00255	CcSEcCtD
Sibutramine—Constipation—Liotrix—hypothyroidism	0.00233	0.00254	CcSEcCtD
Sibutramine—Headache—Dextrothyroxine—hypothyroidism	0.00232	0.00253	CcSEcCtD
Sibutramine—Headache—Levothyroxine—hypothyroidism	0.00232	0.00253	CcSEcCtD
Sibutramine—Feeling abnormal—Liotrix—hypothyroidism	0.00224	0.00245	CcSEcCtD
Sibutramine—Gastrointestinal pain—Liotrix—hypothyroidism	0.00223	0.00243	CcSEcCtD
Sibutramine—Nausea—Dextrothyroxine—hypothyroidism	0.0022	0.0024	CcSEcCtD
Sibutramine—Nausea—Levothyroxine—hypothyroidism	0.0022	0.0024	CcSEcCtD
Sibutramine—Urticaria—Liotrix—hypothyroidism	0.00216	0.00236	CcSEcCtD
Sibutramine—Body temperature increased—Liotrix—hypothyroidism	0.00215	0.00235	CcSEcCtD
Sibutramine—Abdominal pain—Liotrix—hypothyroidism	0.00215	0.00235	CcSEcCtD
Sibutramine—SLC6A3—NRF2 pathway—SLC5A7—hypothyroidism	0.00207	0.0244	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00204	0.024	CbGpPWpGaD
Sibutramine—Hypersensitivity—Liotrix—hypothyroidism	0.00201	0.00219	CcSEcCtD
Sibutramine—Asthenia—Liotrix—hypothyroidism	0.00195	0.00213	CcSEcCtD
Sibutramine—Pruritus—Liotrix—hypothyroidism	0.00193	0.0021	CcSEcCtD
Sibutramine—Diarrhoea—Liotrix—hypothyroidism	0.00186	0.00204	CcSEcCtD
Sibutramine—Dizziness—Liotrix—hypothyroidism	0.0018	0.00197	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—NKX2-1—hypothyroidism	0.00174	0.0205	CbGpPWpGaD
Sibutramine—Vomiting—Liotrix—hypothyroidism	0.00173	0.00189	CcSEcCtD
Sibutramine—Rash—Liotrix—hypothyroidism	0.00172	0.00188	CcSEcCtD
Sibutramine—Dermatitis—Liotrix—hypothyroidism	0.00171	0.00187	CcSEcCtD
Sibutramine—Headache—Liotrix—hypothyroidism	0.00171	0.00186	CcSEcCtD
Sibutramine—Nausea—Liotrix—hypothyroidism	0.00162	0.00177	CcSEcCtD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00161	0.0189	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00147	0.0173	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.0013	0.0154	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—SLC5A7—hypothyroidism	0.00123	0.0145	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00122	0.0144	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—SLC5A5—hypothyroidism	0.00109	0.0128	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00108	0.0127	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00104	0.0122	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—SLC5A5—hypothyroidism	0.000933	0.011	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—SLC5A5—hypothyroidism	0.000827	0.00974	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00081	0.00955	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—NEFL—hypothyroidism	0.000794	0.00935	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000748	0.00881	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000663	0.00781	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—AVP—hypothyroidism	0.000662	0.0078	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00062	0.0073	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000588	0.00693	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000549	0.00647	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000521	0.00614	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000463	0.00546	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.00041	0.00483	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000299	0.00352	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00027	0.00318	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000265	0.00312	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000235	0.00277	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000219	0.00258	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000208	0.00246	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—IYD—hypothyroidism	0.000137	0.00162	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ATP5O—hypothyroidism	0.000117	0.00137	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—POMC—hypothyroidism	0.000116	0.00137	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—TPO—hypothyroidism	0.00011	0.00129	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—TSHB—hypothyroidism	5.07e-05	0.000598	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	4.52e-05	0.000533	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SLC5A5—hypothyroidism	3.8e-05	0.000447	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—POMC—hypothyroidism	1.99e-05	0.000234	CbGpPWpGaD
